Chromogranin A-derived peptide CGA47-66 protects against septic brain injury by reducing blood-brain barrier damage through the PI3K/AKT pathway
作者全名:"Wang, FengLin; Zeng, Yan; Liu, Xian; Cao, JiaJun; Kang, ShengNan; Zhou, WuShuang; Chen, XiaoYing; Liu, JingLun; Zhang, Dan"
作者地址:"[Wang, FengLin; Zeng, Yan; Liu, Xian; Cao, JiaJun; Kang, ShengNan; Zhou, WuShuang; Liu, JingLun; Zhang, Dan] Chongqing Med Univ, Dept Emergency, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Zeng, Yan] Chongqing Univ, Intens Care Unit, Cent Hosp, Chongqing 400016, Peoples R China; [Chen, XiaoYing] Chongqing Med Univ, Dept Surg Care Unit, Affiliated Hosp 1, Chongqing 400016, Peoples R China"
通信作者:"Zhang, D (通讯作者),Chongqing Med Univ, Affiliated Hosp 1, Emergency Dept, 12th Floor,Bldg 5A,1 Youyi Rd, Chongqing 400016, Peoples R China."
来源:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ESI学科分类:BIOLOGY & BIOCHEMISTRY
WOS号:WOS:000791299100010
JCR分区:Q2
影响因子:3.1
年份:2022
卷号:605
期号:
开始页:162
结束页:170
文献类型:Article
关键词:Septic brain injury; Blood-brain barrier; Cognitive impairment; <p>PI3K/AKT</p>; CGA(47-66)
摘要:"CGA(47-66) (Chromofungin, CHR), is a peptide derived from the N-terminus of chromogranin A (CgA), has been proven to inhibit the lipopolysaccharide (LPS)-induced brain injury. However, the underlying mechanism is still unknown. We found that CGA(47-66) exerted a protective effect on cognitive impairment by inhibiting the destruction of the blood-brain barrier (BBB) in the LPS-induced sepsis mice model. In addition, the hCMEC/D3 cell line was used to establish an in vitro BBB model. Under LPS stimulation, CGA(47-66 )could significantly alleviate the hyperpermeability of the BBB, the destruction of tight junction proteins, and the rearrangement of F-actin. To investigate the underlying mechanism, we used LY294002, a PI3K inhibitor, which partially reduced the protective effect of CGA(47-66) on the integrity of BBB. Indicating that the PI3K/AKT pathway plays a vital role in the brain-protective function of CGA(47-66), which might be a potential therapeutic target for septic brain injury. (C)& nbsp;2022 Elsevier Inc. All rights reserved."
基金机构:
基金资助正文: